Reduced Effectiveness and Comparable Safety in Biweekly Vs. Weekly PEGylated Recombinant Human Growth Hormone for Children with Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial.
Frontiers in Endocrinology（2021）
关键词
growth hormone deficiency,PEGylated recombinant human growth hormone,PEG-rhGH,IGF-2,children
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要